Breast Cancer Action Quebec (formerly Breast Cancer Action Montreal) advocates for breast cancer prevention and the elimination of environmental toxins linked to the disease. We work to empower people to make the societal changes needed to stop the disease before it starts.



FemmeToxic's goal is to educate young Canadian women about the potential dangers of cosmetics ingredients and provide people with the tools they need to create personal change and to influence national legislative reform. Refuse to be “toxified”! Demand safer cosmetics!

Prevention and Action against Cancer and Toxicants
The PACT project is an education and mobilization project for Quebec community groups with the goals of sensitizing them to the dangers of toxicants in consumer products.


3I: Influence, Initiate, Impact is created to address the leadership component of FemmeToxic by working with five young women's community groups in and around Montreal. 3I will help promote young women's leadership in community, civic and political actions. This is an exciting opportunity for us to work with young leaders!

Hands off my Hormones! Take a Stand against Endocrine Disruptors: Campaign launched to inform people of the disastrous, multiple effects of endocrine disrupting chemicals (EDCs) on human health. Studies have shown them to be linked to breast cancer, prostate cancer and other chronic illnesses. They are ubiquitous; found in cosmetics, cleaners, canned foods and cars.

What's happening

Editorial: More critical thinking, more debate

By Jennifer Beeman, Executive Director, Breast Cancer Action Quebec

Here is the latest edition of Breast Cancer Action Quebec’s wonderful newsletter. Produced by a team of committed professionals, this is not your average community group newsletter.

Our semi-annual online publication contains original articles, reprints and translations of important writing published elsewhere, plus the feature section More News to Peruse: links to wide-ranging news of interest including recent scientific articles.

However, in our world of fleeting, Web-based news, there is a tendency to read or skim articles that correspond to our own view of the world. At the same time, news media outlets are increasingly owned by fewer companies, as are institutions in many sectors. These trends mean that genuine debate—exchanging viewpoints and contrasting the emerging scientific consensus—is becoming much less common, despite the feeling that we are inundated with news.

To combat this trend, we are launching a new feature, Debates. The field of breast cancer urgently needs more vibrant debates, exchanges and discussions that include a wide range of voices. Discussions tend to be dominated by institutions seeking to maintain control of the discourse on specific issues (the complex issues concerning mammography are a prime example), rendering other issues invisible (a good example of this are the environmental causes of breast cancer).

May 11 2016 - 10:15pm

SABCS 2015: Who Can Skip Chemo? Looking for Answers in Molecular Signatures

Note from Patricia Kearns, Research and Networking Advisor, BCA-Qc

This blog posting from Breast Cancer Action reports on the 2015 San Antonio Breast Cancer Conference. We thought it would be of interest to you.

When I was diagnosed with breast cancer last year, I did not know about the Oncotype DX diagnostic test. It was brought to my attention by a friend just prior to my surgery. She explained that the test is covered by RAMQ for eligible women (who must be hormone positive and lymph node negative).  It is a tool to help determine whether chemotherapy will be beneficial for you or not.  I was not eligible for the test as I was lymph node positive; my oncologist said if that had not been the case, he would have agreed to have the test done, in which case some of my breast tissue would have been sent to California.

It is encouraging to see the advances taking place with this kind of testing so that, down the road, people who are lymph node positive will also be able to use predictor tests. Every woman should have as much information as is available about her body and possible treatment outcomes—no one should have to go through chemo unnecessarily! If you are a newly diagnosed breast cancer patient, talk to your oncologist about this test.

May 11 2016 - 10:02pm